Viewing Study NCT02964559


Ignite Creation Date: 2025-12-24 @ 2:38 PM
Ignite Modification Date: 2026-01-29 @ 2:57 PM
Study NCT ID: NCT02964559
Status: COMPLETED
Last Update Posted: 2024-06-26
First Post: 2016-11-07
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Pembrolizumab in Patients With Locally Advanced or Metastatic Skin Cancer
Sponsor: Emory University
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-01-27
Start Date Type: ACTUAL
Primary Completion Date: 2021-05-18
Primary Completion Date Type: ACTUAL
Completion Date: 2021-05-18
Completion Date Type: ACTUAL
First Submit Date: 2016-11-07
First Submit QC Date: None
Study First Post Date: 2016-11-16
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2024-02-23
Results First Submit QC Date: None
Results First Post Date: 2024-06-26
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-06-25
Last Update Post Date: 2024-06-26
Last Update Post Date Type: ACTUAL